Ionis Pharmaceuticals (IONS) PT Lowered to $85 at Barclays
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $55.06 -1.06%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Join SI Premium – FREE
Barclays analyst Eliana Merle lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $85.00 (from $90.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Ionis Pharmaceuticals (IONS) PT Lowered to $54 at BMO Capital Post Pelacarsen Failure
- Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
